Cargando…
Saliva for use with a point of care assay for the rapid diagnosis of COVID-19
Autores principales: | SoRelle, Jeffrey A., Mahimainathan, Lenin, McCormick-Baw, Clare, Cavuoti, Dominick, Lee, Francesca, Thomas, Abey, Sarode, Ravi, Clark, Andrew E., Muthukumar, Alagarraju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476885/ https://www.ncbi.nlm.nih.gov/pubmed/32910978 http://dx.doi.org/10.1016/j.cca.2020.09.001 |
Ejemplares similares
-
SARS-CoV-2 coinfections with variant genomic lineages identified by multiplex fragment analysis
por: Lueking, Richard, et al.
Publicado: (2022) -
‘nAb’ the self-reactive activity in the COVID-19 combat
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021) -
Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2
por: McCormick-Baw, Clare, et al.
Publicado: (2020) -
Silent SARS-CoV-2 Infections, Waning Immunity, Serology Testing, and COVID-19 Vaccination: A Perspective
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021) -
Variable Creatinine Levels in Critical Care Patients: A Concerning Knowledge Gap
por: Shah, Trushil, et al.
Publicado: (2021)